Anti-CD19 antibody [EPR23174-145] (Ab245235)

推荐稀释比例

• IHC-P1/1000
• mIHC1/1000
• WB1/1000
• ICC/IF1/50
• Flow Cyt1/500
• IP1/30
• IHC-Fr1/250

Anti-CD19 antibody [EPR23174-145] (ab245235) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, ICC/IF, IHC-Fr, IHC-P, IP, WB, mIHC in mouse samples. Anti-CD19 antibody [EPR23174-145] (ab245235) has been cited over 21 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-CD19 antibody [EPR23174-145] (ab245235) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-CD19 antibody [EPR23174-145] (ab245235) has 4 independent reviews from customers. Anti-CD19 antibody [EPR23174-145] (ab245235) specifically detects CD19 (UniProt ID: P25918; Molecular weight: 58kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR23174-145 - ab267394. Antibody clone EPR23174-145 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, APC, PE, Alexa Fluor® 647 ( ab270176, ab270178, ab306537, ab314289 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.